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Fluorescent proteins of the EosFP clade: intriguing
marker tools with multiple photoactivation modes
for advanced microscopy
Karin Nienhaus a and Gerd Ulrich Nienhaus *abcd
Optical fluorescence microscopy has taken center stage in the exploration of biological structure and dynamics,
especially on live specimens, and super-resolution imaging methods continue to deliver exciting new insights
into the molecular foundations of life. Progress in the field, however, crucially hinges on advances in fluorescent
marker technology. Among these, fluorescent proteins (FPs) of the GFP family are advantageous because they
are genetically encodable, so that live cells, tissues or organisms can produce these markers all by themselves.
A subclass of them, photoactivatable FPs, allow for control of their fluorescence emission by light irradiation,
enabling pulse-chase imaging and super-resolution microscopy. In this review, we discuss FP variants of the
EosFP clade that have been optimized by amino acid sequence modification to serve as markers for various
imaging techniques. In general, two different modes of photoactivation are found, reversible photoswitching
between a fluorescent and a nonfluorescent state and irreversible green-to red photoconversion. First, we
describe their basic structural and optical properties. We then summarize recent research aimed at elucidating
the photochemical processes underlying photoactivation. Finally, we briefly introduce various advanced imaging
methods facilitated by specific EosFP variants, and show some exciting sample applications.
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Introduction
Optical fluorescence microscopy has become a central experimental
technique in the life sciences, allowing researchers to study
biological structure and dynamics in specimens ranging from
cells to tissues to entire organisms.1,2 This development was
strongly driven by technological advances of microscopy components,
including light sources (lasers), detectors (cameras, photo-
diodes), micromechanical and optical devices, electronics and
computers. Nowadays, fluorescence microscopy with visible
and near-infrared light is a highly sensitive, minimally invasive
method to investigate live samples on time scales ranging from
split seconds all the way up to many days and weeks. More
recently, visualization of biological structures has become
possible even at the molecular scale through the invention
of super-resolution imaging techniques that bypass Abbe’s
diffraction limit in ingenious ways and offer theoretically
unlimited image resolution.3–9 Despite all this progress,
fluorescence microscopy could not have taken such a central
role in the life sciences if it were not for parallel advances in an
entirely different area, i.e., the development of luminescent
marker tools. By selective and specific staining, biological
molecules and structures become visible under the microscope
and can be studied without interference from a myriad of other
molecules in the specimen.
A vast array of approaches have been accumulated to achieve
specific labeling of samples for fluorescence microscopy.10,11
To accommodate the requirements of specific imaging
experiments, an impressive variety of organic dyes and nano-
crystals with intriguing photochemical properties have been
synthesized, and intricate conjugation strategies have been
devised for their selective attachment to target structures.11–13
In this account, we focus on fluorescent proteins (FPs) of the
green fluorescent protein (GFP) family, which have become
truly enabling tools for fluorescence imaging.14–17 Their key
advantage over other labeling procedures is their genetic
encodability. For example, the gene of a protein of interest can
be extended to include the DNA code of a FP and introduced
into the genome of a biological system (cell or organism).
Subsequently, the sample produces the fluorescent fusion
protein; no other preparative procedures are needed for labeling.
While this approach is conceptually simple, it may take
considerable effort to engineer a fusion protein in which the
additional FP domain has minimal adverse effects on the
biological function of the protein of interest, e.g., by designing
appropriate amino acid linkers and selecting a suitable location
for FP insertion. Notably, protein labeling via FP fusions has
become even more powerful with the advent of CRISPR/Cas9
technology (recognized by the Nobel Prize in Chemistry 2020),
which enables facile modification of target genes at their specific
locus within the genome.18 Therefore, FP technology greatly
facilitates the selective study of a protein in a cell or organism
using fluorescence microscopy, requiring only established and
straightforward genome modifications. Remarkably, although
GFP was discovered as early as 1962 by Osamu Shimomura in
tissue extracts of the jellyfish Aequorea victoria,19 it took more
than three decades until the GFP gene20 was recombinantly
expressed in Escherichia coli and Caenorhabditis elegans by
Martin Chalfie and co-workers,21 and the advantage of genetic
encoding of fluorescence markers was fully appreciated.
FP marker optimization by genetic
engineering
All GFP-type proteins are made from polypeptide chains of
B220–240 amino acids that are folded into 11 b-strands forming
a barrel-like structure, which is capped by short helical sections
and loops at either end, as shown for EosFP in Fig. 1a.22–24 A
helix running along the central axis of the barrel is interrupted
by the chromophore, 4-(p-hydroxybenzylidene)-5-imidazolinone
(p-HBI) and variants thereof in yellow or red FPs, which forms
autocatalytically from a tripeptide (His62-Tyr63-Gly64 in EosFP,
Fig. 1b). The Gly and Tyr residues are strictly conserved in
Fig. 1 Overall structure of EosFP, a GFP-type protein. (a) Each monomer
folds into an eleven-strand b-barrel, with the ends closed by loops and
short a-helical structures. An a-helix running along its axis is interrupted by
the chromophore generated from the tripeptide His62-Tyr63-Gly64.
It is displayed in stick representation in the barrel and as a close-up.
The N- and C-terminal fractions of the b-can that result from cleavage of
the EosFP polypeptide chain upon green-to-red photoconversion are
colored in magenta and green, respectively. (b) Chromophore-forming
tripeptide (left, Ca atoms marked with magenta dots) and mature
green and red chromophores (right, conjugated p-systems colored in
green and red, respectively). (c) Tetrameric arrangement of protomers
A–D, showing the hydrophilic AC and BD interfaces and the hydrophobic
CD interface.
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natural FP sequences, but the first amino acid of the triad may
vary. Naturally occurring FPs have serious drawbacks for use as
fluorescence markers, and tremendous efforts have been made
to optimize them or to endow them with entirely new properties
by genetic engineering. In the 1990s, Tsien and coworkers
pioneered the engineering of advanced GFP variants, featuring
bright fluorescence emission ranging from blue to yellow.25
Subsequently, homologs of GFP were discovered in anthozoa
and other animals,26–31 so that a wide variety of FP sequences for
development of FP markers became available. In some of
these FPs, attractive new properties were discovered, notably,
fluorescence emission in the red spectral region.32,33
Red emission is highly desirable for bioimaging, as cellular
autofluorescence and light scattering are markedly reduced
in the red spectral region. Other FPs displayed intriguing
changes in their fluorescence properties in response to light
exposure. This effect, known as photoactivation,34–41 is most
attractive for fluorescence microscopy and affords new
experimental approaches, e.g., pulse-chase imaging and super-
resolution single molecule-based localization microscopy
(SMLM).
Various biochemical and photochemical properties affect an
FP’s performance as a fluorescence marker.25,42 Biochemical
properties that are targeted for FP marker optimization by
amino acid modifications include the following: (1) DNA
sequences are adjusted for optimal codon usage in cells chosen
to express the FP marker. (2) Natural FPs typically form tetra-
meric (or in some cases dimeric) quaternary structures.
Whereas this is not of concern in simple marker applications,
e.g., highlighting cellular organelles, cells and tissues,43,44 the
most prevalent application, i.e., selective protein labeling,
requires monomeric FPs. If the FP marker has a tendency to
oligomerize, this property is passed on to the fusion protein
and typically causes severely compromised biological
functions.45 Therefore, researchers aim to disrupt the binding
interfaces between FP protomers by exchanging amino acids,
e.g., by replacing hydrophobic amino acid residues with hydro-
philic or even charged ones. Sometimes, a single mutation
suffices to render a FP monomeric, as was the case for the
dimeric natural Aequorea GFP.46 However, for anthozoan FPs,
monomerization efforts have oftentimes proven extremely
difficult.47–49 (3) After synthesis in the ribosome, only a fraction
of polypeptide chains coding for a FP fold properly and form a
functional fluorophore in the process, resulting in a maturation
efficiency of less than one. Accordingly, the marker appears
less bright (as judged from the overall sample staining), and
the number of molecules is underestimated in quantitative
fluorescence imaging studies. Therefore, it is highly desirable
to optimize maturation by introducing suitable mutations.50 (4)
Equally important is the temperature dependence of the
maturation efficiency. It is typically high up to room temperature,
in accordance with the environmental temperature of the
organism from which the FP sequence was taken, but markedly
declines above. Live-cell imaging of mammalian cell cultures
require a temperature of 37 1C, however. Fortunately, the
exchange of certain amino acids in the sequence has frequently
been successful to generate thermostable variants expressing
well at 37 1C.51,52 (5) Chromophore maturation may take
from minutes to hours or even days for particular FPs,50,53
requiring molecular oxygen (O2) as the only further ingredient.
In live imaging, fast maturation can be important, e.g., in
developmental studies, so that marker production can keep
up with the processes under study.
Photochemical and photophysical properties of an FP marker
can also be improved by genetic engineering, as the protein
matrix modulates the chromophore environment in different
ways and changes its properties as a marker dye. Accordingly,
(1) color tuning of the absorption and emission bands can be
achieved by amino acid replacements within (e.g., Tyr to Phe or
His) and near the chromophore.25 An important role of the
protein matrix is to constrain the dynamics of the p-HBI
chromophore (or its derivatives) to keep it preferentially in a
coplanar configuration.54 In fact, p-HBI freely diffusing in water
is completely non-fluorescent.55 Amino acid exchanges that
lead to a strengthening of the overall fold or chromophore
interactions with the surrounding amino acids (and structural
water molecules) can improve both (2) the absorption strength
and (3) the fluorescence quantum yield (QY). (4) The photo-
bleaching probability is also likely to depend on the rigidity of
the FP scaffold and the enclosed fluorophore. As a case in
point, oxygen plays an important role in photobleaching, and
its diffusion to the fluorophore may be hindered in a more rigid
environment. The photobleaching probability is a crucial
performance parameter, as it represents the limited overall
number of excitation/emission cycles of the fluorophore.
Another important issue is (5) the protonation of the p-hydro-
xyphenyl moiety of the p-HBI chromophore, which affects the
spectral properties in a major way. The neutral, protonated
chromophore is usually non-fluorescent and its spectra are
markedly blue-shifted from those of the anionic, deprotonated
chromophore. In most (but not all) GFP-type proteins, its
population varies with the pH of the protein environment.
To ensure that the anionic chromophore is the predominant
species at physiological pH, mutations can be introduced
near the chromophore to lower its pK. Finally, we mention
the (6) photoactivation capability, denoting photoinduced
modifications of the FP’s fluorescence properties. Two modes
are being distinguished: Reversible photoactivation (photo-
switching) typically arises from chromophore toggling between
its trans and cis configurations, only one of which emits
fluorescence with high yield. Irreversible photoactivation
(photoconversion) refers to a permanent photochemical
modification. Consequently, a non-fluorescent (dark) state
may get photoactivated to a fluorescent (bright) state, or a
bright state may be turned into another bright state with a
different emission color (wavelength). A few FPs even combine
reversible and irreversible modes. Photoactivation is a very
attractive property, in fact, a prerequisite for some powerful
imaging modalities. Consequently, considerable efforts have
been made to optimize photoactivation properties of FPs, as we
will discuss in detail below, using EosFP and its derivatives as
an example.
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Photoactivatable EosFP and its
engineered descendants
Green-to-red photoconvertible FPs change their emission color
in response to light irradiation, most effectively with violet light
(wavelength B400 nm). Miyawaki and coworkers were the first
to report this property for Kaede, a FP that they isolated from
the stony coral Trachyphyllia geoffroyi.56 Soon thereafter, we
introduced EosFP,22,57 originating from the scleractinian coral
Lobophyllia hemprichii. Since then, the class of photoconvertible
FPs has been greatly expanded with advanced EosFP
variants,51,58–61 Dendra262,63 and variants,64 KikGr65 and its
monomeric form mKikGr,66 mClavGR2,67 mMaple,68
pcDronpa,69 SAASoti,70,71 and a few other proteins.31,72,73
Among the latter, the ‘‘least evolved ancestor (LEA) protein’’
is an interesting example of an FP designed in the laboratory.73
Early on, it was realized that photoconvertible FPs enable
regional optical marking, which can be exploited for pulse-
chase imaging.36,56,57,74,75 Selective irradiation tags FPs within
a certain region of a specimen by converting them to red
emitters, and then they are ‘‘chased’’ by imaging until they
photobleach. In their Nobel prize-winning work in 2006,
Betzig’s group demonstrated single-molecule localization
microscopy (SMLM) as a super-resolution imaging technique,
using green-to-red photoconversion of a tandem-dimeric EosFP
variant.5 Their work triggered efforts to engineer optimized
photoconvertible FPs for super-resolution imaging. Remarkably,
in EosFP, only a small number of amino acid exchanges sufficed
to improve its marker properties and even to endow it with new
properties beneficial for imaging. This likely explains its wide-
spread use as a template for further FP development, as shown
in the evolutionary tree in Fig. 2. There, we have limited
ourselves to FP markers; sensors are not included.
The four protomers A, B, C and D of natural EosFP associate
via two types of interfaces, one with hydrophobic (AB, CD
binding) and one with hydrophilic (AC, BD binding) character,
to form a tightly associated tetramer (Fig. 1c).22 Single amino
acid exchanges, Val123Thr and Thr158His, were sufficient to
break up the AB and AC interfaces, respectively, resulting in
dimeric variants, d1EosFP and d2EosFP (Fig. 2). Combining
both mutations yielded a bright, monomeric variant,
mEosFP.22 It has found widespread application in fluorescence
imaging of plants,61 but not mammalian cells due to its low
maturation efficiency above 30 1C. As an intermediate remedy,
we designed a ‘‘pseudo-monomeric’’ marker by connecting two
protomers of d2EosFP with a 12 amino-acid linker, which
expresses well at 37 1C.74 Accordingly, this tandem-dimeric
variant (tdEosFP) is twice as bright as the monomer and,
therefore, attractive for imaging applications for which the
label size is not of concern.5,76–79 Another immediate descendant
of EosFP is its Phe173Ser mutant, denoted IrisFP,80 which
combines photoconversion and photoswitching in the same
FP, thereby enabling pulse-chase imaging with super-resolution
via SMLM.
Subsequently, we found that a single point mutation in
mEosFP, Ala69Val, provided an enhanced temperature
tolerance, resulting in a bright marker for 37 1C expression,
mEosFPthermo.58 As its other parameters remained unchanged
within the experimental error, which is not surprising for such
a tiny modification of a hydrophobic side chain, we never
published its detailed characterization. So far, three further
variants originated from mEosFPthermo (Fig. 2). Mutant
Ala69Thr (pr-mEosFP) features ‘‘primed photoconversion’’,
i.e., photoactivation using combined blue-green (e.g., 488 nm)
and far-red (600–850 nm) irradiation (vide infra) instead of
400 nm light.81 Monomeric IrisFP51 was also engineered from
mEosFPthermo as well as a variant denoted mIrisGFP,82 showing
reversible photoswitching but not green-to-red photoconversion.
It is quite remarkable that such a diversity in photoactivation
behavior can arise from a fairly small number of amino acid
replacements (Fig. 3a).
In parallel, McKinney et al.59 also pursued engineering of a
monomeric EosFP expressing at 37 1C. Their variant, mEos2,
however, had a higher dimerization tendency (KD = 20 mM) than
its parent, mEosFP (233 mM), or mEosFPthermo (483 mM),60 which
can be problematic at higher expression levels. This protein
served as a starting point for further modifications. In an attempt
Fig. 2 Evolutionary tree of photoactivatable EosFP. The oligomerization
state is represented by the number of protein depictions, the background
color encodes the photoactivation mode (photoconvertible, green/
magenta; photoswitchable, green/light green; photoconvertible and
photoswitchable, green/light green/magenta/light magenta).
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to improve mEos2, mEos3.1 and mEos3.2 were introduced,
reported to be truly monomeric, brighter and faster maturing
than Eos2.60 Variants mEos4a and mEos4b were engineered that
are able to fluoresce and photoconvert in heavily fixed (up to 1%
OsO4), epoxy resin-embedded samples for correlative light and
electron microscopy (CLEM).83 A further descendant of Eos4b,
mEosEM, was recently reported to resist epon resin embedding
after OsO4 treatment.
84 Moreover, Chang et al.85 prepared a series
of mutants by replacing His62, the first amino acid in the
chromophore tripeptide, which is essential for green-to-red photo-
conversion, by other amino acids, yielding monomeric green
EosFP (mGeos) variants with useful photoswitching capabilities.
Amino acid modifications of Eos2 descendants are shown in
Fig. 3b.
Optical and structural properties of
EosFP-type chromophores
Molecular brightness
Besides the photobleaching probability, molecular brightness is
another important quantity that allows microscopists to assess a
marker’s performance in fluorescence imaging. Molecular
brightness is the product of two photophysical quantities, the
extinction coefficient, e, measured at the peak of the absorption
band, and the fluorescence QY, denoting the probability of
photon emission after photon absorption. In Table 1, we have
compiled literature values of these quantities for both green and
red (anionic) chromophore species of EosFP variants. They are
expected to differ somewhat between variants due to the altered
structure and dynamics of the chromophore and its environment.
Table 1 shows QY values ranging from 0.64–0.91 and 0.47–0.75 for
the green and red chromophores, respectively. Interestingly, the
two extreme values for the red fluorophore were obtained on the
same variant, namely Eos2, by two different laboratories. Thus, we
conclude that published QY values should be taken with a grain of
salt, even though their determination relative to a standard
dye involves a simple measurement. Likewise, e values differ
not only between variants, but also for the same variant
measured by different laboratories (Table 1). A stunning
example is mEosFPthermo, for which e values of 27 000 and
97 000 M1 cm1 and 10 000 and 41 300 M1 cm1 have been
reported for the green and red chromophore species, respec-
tively. As we will briefly discuss in the next subsection,
published e values (Table 1) are only ‘‘apparent’’ parameters.
Their determination is not trivial, and errors, assumptions
and corrections involved in the process can lead to different
results, but cannot explain discrepancies by as much as three-
to fourfold. To conclude this subsection on a critical note,
selecting a FP marker protein based on published parameters
may not necessarily guide the user to the best choice.
Fig. 3 Genetic engineering of EosFP. Protomers are shown in cartoon representation; mutated residues are depicted in van der Waals representation,
using the same colors as for the list of engineered variants below (with sequence changes specified in parentheses). (a) Modifications of EosFP to obtain
monomeric mEosFP (red), the thermostable mEosFPthermo and the primable pr-mEosFP variants (orange), and mIrisFP (magenta). (b) Additional
modifications of mEosFP to obtain mEos2 (magenta), mEos3.1 and mEos3.2 (blue) and mEos4a and mEos4b (orange).
Table 1 Reported peak extinction coefficients, e, and fluorescence quan-
tum yields, QY, of EosFP variants
EosFP variant
Green chromophore Red chromophore
e (M1 cm1) QY e (M1 cm1) QY
EosFP 72 00057 0.7057 41 00057 0.5557
d1EosFP 74 80057 0.6857 40 00057 0.6257
d2EosFP 57 00059 0.6657 33 00057 0.6057
84 00057 49 00059
tdEosFP 65 00059 0.9160 32 00057 0.6260
84 00057 48 00059
mEosFP 67 20057 0.6457 37 00057 0.6257
72 00060 0.7060 41 00060 0.5560
mEosFPthermo 27 00060 0.6764 10 00060 0.6664
97 20064 0.8460 41 30064 0.6560
mEos2 56 00059 0.8460 41 30060 0.4760
75 400 0.8483 46 00059 0.7583
86 51083 53 53083
61 42083
mEos3.1 88 40060 0.8360 33 50060 0.6260
mEos3.2 63 40060 0.8460 32 20060 0.5560
mEos4a 83 53083 0.8683 61 00083 0.7183
mEos4b 78 17083 0.8483 55 50083 0.7183
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Optical absorption bands of EosFP-type chromophores and
their pH dependence
As a prototypical example, Fig. 4 presents optical absorption
data of mEosFPthermo in the pH range 3–10. Spectra of
the green form (Fig. 4a) show two absorption bands at 390
and 504 nm, denoted A and B,86,87 respectively. Their pH
dependence reveals that the proton concentration in the solvent
controls the fractions of neutral (phenol, A) and anionic
(phenolate, B) green chromophore species residing in the
protein interior.25 The variations of the A and B Band ampli-
tudes with pH (Fig. 4c) deviate from a Hendersson–Hasselbalch
relation, so a simple one-site protonation reaction does not
accurately describe the data. Apparently, multiple protonation
steps govern the neutral and anionic species populations, as
seen before for other FPs.82,88,89 The best fit yields pK = 5.3 
0.1 (green lines in Fig. 4c) as the midpoint of the protonation
transition. The low pK ensures that the majority of proteins is
in the anionic, which is fluorescent form under physiological
conditions. Green and yellow FPs usually have 5.0 o pK o
7.0,90 whereas blue and far-red variants often show pK o 4.90
Interestingly, there is an additional step-wise increase of the B
band amplitude at pH 4 8 in the data in Fig. 4c, reflecting a
deprotonation in the chromophore vicinity that causes a
further increase of e by ca. 20%.
Absorption spectra of red mEosFPthermo in the pH range
3–10 are shown in Fig. 4b. The absorption maxima of the A and
B bands of mEosFPthermo are centered on 461 and 572 nm,
respectively, and both possess a pronounced vibronic fine
structure. Below 400 nm, S0–S2 transitions of the neutral and
anionic red chromophores are apparent. As for the green form,
the pH dependence of the A and B band absorbances (Fig. 4d)
does not follow a simple one-site protonation model due to
interactions between the chromophore and the protein matrix.
Indeed, some FPs do not show a single-step chromophore
protonation at all. Instead, there may be constant A and B
band populations in a certain pH range89,91 or two distinct
protonation steps,82,88 both bearing witness to the strong
electrostatic coupling of the chromophore to the protein
environment.92,93
To compare the absorption strengths of different FP species,
absorption spectra and, specifically, the peak absorbances of
the A and B bands must be converted to extinction coefficients,
respectively, by using Beer’s law. This requires knowledge of the
concentration of our FP solution, which can be determined
spectroscopically from the measured absorbance of our FP
sample at 280 nm and the corresponding calculated extinction
coefficient. We note in passing that mainly tryptophan (e280 =
5500 M1 cm1) and tyrosine (e280 = 1490 M
1 cm1) residues
contribute to the 280 nm protein band.94 If, however, our FP
sample is not 100% pure, other types of proteins contribute to
the 280 nm absorption as well. This results in an artificially
inflated FP concentration and, therefore, a smaller extinction
coefficient of the B band maximum. Moreover, since we aim for
the e value of the pure anionic (B band) species, we either have
to choose a pH at which all chromophores are deprotonated, so
that the A band fraction is zero, or we have to correct with the
known pH dependence (Fig. 4). The just described approach is
arguably most often used to determine e values quoted in
publications, yielding typical values of 70 000–80 000 M1 cm1
for the green EosFP chromophore. It disregards, however, the
presence of non-mature (non-fluorescent) FP species, which can
be viewed as an impurity in the determination of the protein
concentration via the 280 nm band absorption. An alternative e
determination procedure involves taking absorption spectra
before and after base denaturation of the FP sample. Using the
peak extinction coefficient of the chromophore of completely
denatured GFP at pH 13 (e447 = 44 000 M
1 cm1)95 as a
reference, the concentration of green chromophores in the
denatured EosFP sample can be determined. This approach
allows conversion of the peak absorbance of the B band (before
denaturation) into an extinction coefficient, yielding values of
B100 000 M1 cm1 for the green EosFP chromophore (see
mEosFPthermo in Table 1). Once the e value of the anionic
(B band) green species has been determined, the one of the
red species results from the ratio of the B band peak absor-
bances before and after photoconversion. Notably, we convert
only a small fraction of all chromophores to calculate this ratio,
so that the error due to photobleaching is minimized. Finally,
the maturation efficiency of the green FP (ca. 70–80%) can be
calculated from the ratio of the apparent B band peak e values
obtained by using the 447 nm and the 280 nm peak extinction
coefficients.
Isomerization and protonation states of the chromophore
The p-HBI moiety of the chromophore can adopt either a cis or
a trans configuration, which poses a further complication in
Fig. 4 Optical absorption data of mEosFPthermo in the pH range 3–10.
(a) Absorption spectra of the green chromophore; (b) absorption spectra
of the red chromophore. The line colors in the two panels vary from (a)
black to green and (b) black to red to indicate increasing sample pH.
Spectra at pH 7.4 are plotted in blue. (c and d) Normalized peak absorption
of the A (open symbols) and B (closed symbols) bands of the (c) green and
(d) red chromophores. Fits with the Hendersson–Hasselbalch relation,
yielding (c) pK = 5.3 and (d) pK = 5.8, are included as solid lines.
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addition to protonation. The two configurations are shown for
the green EosFP chromophore in Fig. 5a and b, respectively.
The isolated p-HBI chromophore is known to be thermo-
dynamically more stable in the cis form,96 but can easily rotate
around the phenoxy (P) or imidazolinone (I) bonds of the
methene bridge. Note that only rotations around the I-bond
change the isomeric state. Bond rotations open non-radiative
de-excitation pathways, making the free p-HBI dye completely
non-fluorescent in solution.97–99 Therefore, to ensure a high
fluorescence QY, the protein environment must stabilize the
chromophore in one configuration or impose steric restrictions
that prevent isomerization. Most natural FPs host a fluorescent
cis chromophore, with the red-emitting eqFP611100 being a
notable exception.101 Likewise, only a few engineered FPs have
a fluorescent anionic trans chromophore.47,49,52,100–104
In either isomeric state, the hydroxyphenyl moiety of the
chromophore can, in principle, be protonated or deprotonated
(Fig. 5). The corresponding A and B absorption bands of the cis
and trans isomers overlap to a large extent, so it is not
straightforward to unambiguously identify the isomerization
state based on the absorption spectra.82,101,103 Fortunately, the
cis configuration is predominant in EosFP in (dark) equilibrium,




Soon after the discovery of green-to-red photoconversion in
Kaede in 2002,56 Mizuno et al.105 reported key structural
changes resulting from this photoreaction: the polypeptide
chain is cleaved between the Na and Ca atoms of residue 62
in its chromophore tripeptide, His62-Tyr63-Gly64, and the
conjugated p-electron system of the p-HBI chromophore is
extended to include the imidazole sidechain of His62 (Fig. 5c, d),
causing a red shift of its absorption and emission bands. The
two chain fragments are tightly associated and stay together
after photocleavage (Fig. 1a). These structural changes are
characteristic of photoconverting FPs, as subsequently observed
in X-ray structures of several green-to-red photoconverters
including Kaede,106 EosFP,22 Dendra2,63 KikGR,107 LEA73 and
pcDronpa.69 Whereas the end product of this photoreaction is
undisputed, the detailed mechanisms by which it forms are still
controversially debated.
Photoconversion with light around 400 nm implies that the
reaction is initiated by excitation of the neutral chromophore.
Photoconversion via excitation of the anionic (green) chromophore
with intense light (e.g., 488 nm) has also been reported for some
FPs, albeit with low yield.62,108,109 Exposure with far-red light (600–
850 nm) in addition to 488 nm light irradiation has been shown to
greatly enhance the photoconversion yield in some cases.81,110,111
Moreover, photoswitching based on reversible cis–trans
isomerization of the green and red chromophores was observed
in several EosFP variants, e.g., in IrisFP.80 The involved chromo-
phore states and excitation wavelengths are shown schematically
in Fig. 6.112 In the following, we briefly summarize research aiming
to shed light on the mechanisms underlying the different
photoactivation modes.
Green-to-red photoconversion via excitation of the neutral
green cis chromophore
A variety of mechanisms have been invoked to explain peptide
cleavage upon photoconversion, including light-induced
b-elimination,105 unimolecular elimination (E1)107 and also
bimolecular elimination (E2).22 To clarify the reaction
mechanism, computational approaches can in general be quite
Fig. 5 Isomerization and protonation states of the EosFP-type chromo-
phore. (a) Neutral (left) and anionic (right) green trans chromophores. (b)
Neutral (left, with arrows indicating isomerization around the phenoxy (P)
and imidazolinone (I) bonds of the methene bridge) and anionic (right)
green cis chromophores. Non-fluorescent and fluorescent species are
depicted in grey and green, respectively. Absorption and emission spectra
are shown below. Grey: A absorption bands of the neutral cis (and/or trans)
chromophores; dark green: B absorption bands of the anionic (cis and/or
trans) chromophores; bright green: emission spectrum of the anionic
cis species. Cis–trans isomerization is reversible, as indicated by the
grey-green double-headed arrow on the right. (c) Neutral (left) and anionic
(right) red-emitting cis chromophores. Absorption and emission spectra
are plotted below (grey: A absorption bands; red: B absorption bands;
bright red: emission). Green-to-red photoconversion is irreversible, as
indicated by the green-red arrow on the right. (d) Neutral (left) and anionic
(right) red trans chromophores. Cis–trans isomerization is reversible, as
indicated by the grey-red double-headed arrow on the right. Adapted
from ref. 112 with permission from IOP Publishing, copyright 2016.
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helpful. Lelimousin et al.113 used excited-state hybrid quantum-
chemical and molecular mechanics to gain more detailed
insight into photoconversion in EosFP. Their results suggested
that the electronically excited neutral green chromophore (S1
state) switches to the triplet state (T1) and back to the ground
state singlet (S0) surface of the red species. Proton transfer from
His62 to Phe61 was assumed to take place on the S1 surface,
while backbone cleavage was found to occur on the T1 surface.
By contrast, Li et al.114 proposed, based on quantum-chemical and
molecular mechanics calculations using the ONIOM(B3LYP:
AMBER) method, that photoconversion reactions (chromophore
modifications, backbone cleavage) take place in the electronic
ground state.
A number of experimental studies also aimed at elucidating
mechanistic details. Ultrafast spectroscopic studies revealed
that the neutral green chromophore of Dendra2 undergoes
excited-state proton transfer and becomes anionic within a few
picoseconds.115 It remained unclear, however, if this species is
involved in photoconversion. In a spectroscopic study of Kaede,
backbone cleavage in the excited state was observed within
20 ps after excitation of the neutral green chromophore, generating
the neutral red chromophore.116 This result is in support of
earlier reports claiming that efficient photoconversion occurs
via excitation of the neutral green chromophore.105,107,117
Notably, the picosecond timescale of the photoreaction may
exclude the involvement of states with different spin multi-
plicity, which was proposed by Lelimousin et al.113 Based on
time-resolved UV/vis and FTIR spectroscopy, Fare et al.118
recently suggested that photoconversion of EosFP is initiated
by oxidation of the neutral green chromophore in the ground
state via a tyrosyl radical, most likely Tyr177, that is transiently
formed upon light-activation.
Wachter and coworkers119 performed structural studies on
variants of a synthetic FP, denoted ALL-GFP, that was derived
by statistical inference as the common ancestor of all FPs in the
great star coral Montastraea cavernosa.120 They identified a least
evolved ancestor, LEA, which harbors 13 mutations (including
Gln62His in the chromophore triad), which was the minimum
number necessary for efficient green-to-red photoconversion.
A key finding was that the protein matrix around LEA’s
chromophore is more dynamic than the one of ALL-GFP,
permitting substantial chromophore rearrangements in
response to photoexcitation. Moreover, it was proposed that
chromophore twisting is a pre-requisite for disruption of the
electrostatic network and activation of a proton shuttling
mechanism required for photoconversion.
From these computational and spectroscopic studies, it is
evident that a great deal has been learned about photoconversion
by excitation of the neutral species. However, our understanding of
the detailed mechanism is still fragmented, and we expect further
exciting and clarifying studies in the future.
Photoconversion via excitation of the anionic green
chromophore
In addition to excitation of the neutral green chromophore with
B400 nm light, excitation of the anionic green chromophore
with 488 nm light was also found to induce photoconversion in
Dendra2,62 albeit with markedly lower yield compared to excitation
of the neutral form ref. 109. Pantazis and co-workers studied
photoconversion on Dendra2 and observed that simultaneous
exposure to 730 nm light in addition to 488 nm light for excitation
of the green anionic chromophore markedly increased the photo-
conversion yield. They coined the phrase ‘‘primed conversion’’ for
this process and proposed that the priming laser (B488 nm)
excites the green anionic chromophore and drives it into a primed
(intermediate) state.121 In this state, absorption of a second photon
of lower energy (730 nm) triggers the transition to the electronic
ground state of the red species.
Recently, Mohr et al.81 and Turkowyd et al.111 reported in
parallel that the enormous, near-IR induced enhancement of
green-to-red photoconversion via excitation of the anionic
green chromophore is characteristic of green-to-red photo-
convertible FPs carrying a threonine at sequence position 69.
Amino acids in this position can regulate chromophore–protein
interactions. In EosFP, Arg66 provides negative charge stabili-
zation on the imidazolinone ring by hydrogen bonding of its
guanidino moiety to the imidazolinone carbonyl oxygen.22 If
there is a Thr69 instead of alanine, as in the natural Dendra2
sequence63 and mEos2 Ala69Thr (pr-mEos2),122 however, the
Arg66 side chain hydrogen-bonds to the Thr69 hydroxyl, so that
the chromophore becomes overall more flexible. Thus, the
interaction of Thr69 with Arg66 is likely responsible for the
appreciable photoconversion yield of Dendra2 upon excitation
of the anionic green chromophore with 488 nm light in a
confocal microscope,62 and the enhanced yield upon near-
infrared light exposure.
To elucidate the conversion mechanism, we studied the
yield of photoconversion as a function of the wavelength of
Fig. 6 Transitions between EosFP-type chromophores. (a) Green (green
box) and red (red box) chromophore states. C, cis. T, trans. Superscripts
indicate the protonation state (H, protonated; , deprotonated). Colored
arrows represent light-induced transitions: 405 nm (violet), 473 or 488 nm
(blue), 532 or 561 nm (green). Grey arrows indicate the pH-dependent
ground state equilibria. (b) Absorption spectra of green and red pr-
mEosFP, with absorption bands (A, B, S0–S2) labeled in the corresponding
colors. Wavelengths of photoactivating laser irradiation are indicated by
arrows (color-coding as in panel (a)).
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the red light for Dendra2 and pr-mEosFP. Primed conversion is
effective between 600 and 850 nm; the action spectra of the two
FPs are similar in shape and show two slightly shifted peaks.81
Fluorescence quenching experiments revealed that the primed
state is a triplet state with a lifetime of B5 ms.81 By using near-
infrared transient absorption spectroscopy, Byrdin et al.123
identified a similar, long-lived triplet state after 488 nm excitation
in IrisFP and enhanced GFP (eGFP), which do not have a
threonine at sequence position 69 (EosFP numbering). They
suggested that such a state may be common to all green p-HBI
chromophores and involved in oxidative photochemical processes
such as primed photoconversion or ‘‘oxidative redding’’,124 the
oxidant-mediated green-to-red photoconversion of eGFP. If that
were the case, the crucial role of Thr69 would then be to facilitate
formation of the red chromophore, presumably by enhancing the
structural flexibility of the intermediate state. Further spectro-
scopic studies will likely shed light onto the details of this
photoreaction.
Reversible cis–trans isomerization of the green and red
chromophores
In 2008, Adam et al.80 reported photoswitching in IrisFP, the
Phe173Ser mutant of tetrameric EosFP. By using X-ray crystal-
lography and (in crystallo) optical spectroscopy, we showed that
IrisFP displays reversible photoswitching between a bright
green and a dark state via cis–trans isomerization of the
chromophore, photoconverts irreversibly to the red-emitting
state under violet light and exhibits reversible photoswitching
also in the red form, again via cis–trans isomerization of the
chromophore. Apparently, the significantly increased free
volume in the chromophore pocket due to the amino acid
exchange facilitates isomerization. Subsequently, monomeric
FP variants were introduced that combine reversible and
irreversible photoactivation, mIrisFP51 and NijiFP.64
Reversible photoswitching of the green chromophore was
analyzed in great detail in mIrisGFP (mEosFPthermo Phe173-
Ser) by using optical spectroscopy.82 This IrisFP variant was
engineered to be monomeric but lost its green-to-red photo-
conversion capability in the process. Interestingly, it has His62
in the chromophore triad, which is seen as a necessary57
(but apparently not a sufficient) condition for effective photo-
conversion. We found that isomerization and protonation in
mIrisGFP are strictly correlated because of very different acid–
base environments that the chromophore’s hydroxyphenyl
group encounters in the two isomeric forms, so that pKcis E
5.5 and pKtrans 4 10. Consequently, excitation of the anionic cis
chromophore (using 473 nm light) generates the neutral trans
chromophore, and subsequent excitation of the neutral trans
chromophore (using 405 nm light) induces back isomerization
to the anionic cis state. Interestingly, cis–trans isomerization
was much more efficient by exciting the neutral, non-
fluorescent cis chromophore with 405 nm light rather than
the anionic cis chromophore at 473 nm. This observation
can be rationalized by quantum-chemical calculations by
Olsen et al.,125 who found a barrierless energy surface for
excited-state isomerization for the neutral but not for the
anionic chromophore. Colletier et al.126 studied photoswitching
of green IrisFP from the non-fluorescent trans to the fluorescent
cis state by time-resolved absorption spectroscopy. They found
evidence of three intermediate states, two with picosecond and
one with microsecond lifetimes, associated with fast chromo-
phore isomerization in the excited state and slow proton transfer
in the ground state, respectively.
Evidence is mounting that reversible photoswitching is
common to all EosFP variants, although with vastly different
yields. For example, Thedie et al.108 showed that green mEos2
embedded in polyvinylalcohol can be switched off by 488 nm or
strong 561 nm light. As the green-emitting state could readily
be recovered by 405 nm light irradiation, the dark state was
associated with a protonated chromophore either in a twisted
or in a trans configuration. Green-to-red photoconversion of
this dark state via 405 nm light exposure was not observed,
however. A protonated and twisted chromophore was also
generated by irradiation of the green anionic cis chromophore
in the FP LEA.127 In this work, it was suggested that this state
may be able to photoconvert upon 405 nm irradiation, but that
photoswitching back to the anionic cis state is much more
likely. For green mEos4b, a long-lived dark trans state was
found upon 488 nm irradiation and characterized in detail.128
Based on kinetic crystallography, molecular dynamics, and
Raman spectroscopy data, it was found that the relative stability
of the cis and trans chromophores, judged from the number of
hydrogen bonds holding it in place, is an important factor con-
trolling the switching kinetics. Energetic issues of chromophore
stabilization were also addressed in recent work by Boxer and
co-workers,129 who modified the tyrosine moiety of the p-HBI
chromophore in Dronpa2 using amber suppression. Their systema-
tic analysis emphasizes the important role of the chromophore’s
charge distribution for modulating the energy surfaces of the singlet
ground and excited states in response to I and P bond twisting.
Furthermore, there are also observations of photoswitching
within the red form of photoconverting EosFP variants.
Sun et al.130 investigated the effect of formaldehyde fixation
on the photophysical properties of mEos3.2. From their experi-
ments, they concluded that a fraction of red-emitting mEos3.2
molecules enter a long-lived dark state upon 405 nm irradiation
from which they could be recovered by 561 nm irradiation.
Recently, Bourgeois and coworkers131 also identified a long-
lived dark state in the fluorescence emission from individual,
red-converted mEos4b molecules. X-ray crystallography
revealed that the dark-state chromophore is highly dynamic
and adopts a ‘‘frustrated’’ trans conformation, with its
hydroxyphenyl group bent out of plane to avoid steric clashes
with a neighboring residue (Ile157). The absorption maximum
at B475 nm and the finding that re-isomerization occurs upon
405-, 473- and 488 nm light illumination suggested that the
trans chromophore is protonated (see Fig. 6b).
Our mechanistic understanding of the photochemical
processes in EosFP variants is still incomplete, as shown in
this section. Nevertheless, their heuristic optimization for
specific imaging experiments has been enormously successful,
as shown in the following section.
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Advanced optical imaging with EosFP
variants
Pulse chase imaging with conventional fluorescence
microscopy
Optical pulse-chase imaging is a powerful technique to observe
protein dynamics in live cells, tissues, and organisms labeled
with a protein of interest fused to a photoconvertible FP. After
imaging by excitation of the initially green FP, a subpopulation
of molecules is selected and photoconverted by focused light
irradiation to their red-emitting state. Subsequently, migration
of these ‘‘tagged’’ molecules is followed in the red color
channel without interference from newly expressed green-
emitting proteins. 405 nm photoconversion light (typically from
a GaN diode laser) is well separated in wavelength from photo-
excitation light of green (e.g., 473 or 488 nm) or red (e.g., 532 or
561 nm) FP fluorophores (see Fig. 6b), so unintentional photo-
conversion by fluorescence excitation is not an issue.
Fig. 7 shows examples of optical pulse-chase experiments. In
Fig. 7a, the mRNA of tetrameric EosFP was microinjected into a
Xenopus laevis oocyte. At developmental stage 3, one of the four
cells was irradiated with 405 nm light to selectively photoconvert
markers in this cell to the red state; the descendant cells were
subsequently tracked over time. For organelle tracking,
mitochondria in rabbit kidney cells were labeled with tdEosFP
fused to a mitochondrial targeting signal. After photoconversion
of individual mitochondria, migration as well as fusion and
fission of mitochondria could be observed (Fig. 7b). Fig. 7c
shows protein tracking in live cells at 37 1C using the tubulin-
binding protein RITA132 fused to mEosFPthermo. After photo-
conversion in the region marked by the circle, red-emitting RITA
fusion proteins appeared within 20 s in the region marked by the
square in the leftmost image (see close-ups at 0, 20 and 40 s on
the right).
SMLM and super-resolution pulse chase imaging
Super-resolution SMLM is a camera-based widefield microscopy
technique that relies on the localization of individual
fluorophores.5–7 Oftentimes, SMLM is carried out with photo-
activatable FPs, using either green-to-red photoconversion or
reversible photoswitching. Suitable light irradiation ensures that
only a small number of fluorophores are in the emitting state in
a single camera frame (dwell time of milliseconds) and imaged
until they cease to emit, either due to photobleaching or entering
a transient, long-lived dark state. In each image, the spots from
only a few, randomly activated fluorophores are not likely to
overlap spatially. Therefore, the center of gravity of all photon
positions measured for an individual fluorophore before photo-
bleaching can be precisely computed and taken as an estimate of
the fluorophore location. The final image is reconstructed by
superimposing all measured fluorophore locations from a large
number (typically 102–104) of camera frames (Fig. 8).133,134
For SMLM with photoconvertible EosFP variants, we irradiate
the sample with low-intensity 405 nm (Fig. 8a) or dual-color
(primed) photoconverting light (Fig. 8b). Therefore, only a small
number of green fluorophores turn red within each camera
frame and are subsequently localized by imaging with, e.g.,
532- or 561 nm excitation light in the red color channel.
Photoswitchable EosFP variants are so-called ‘‘negative’’
photoswitchers,38,135–137 i.e., upon excitation of their anionic
fluorescent species (with 473- or 488 nm light for green-
emitting FPs) off-switching competes with fluorescence. Thus,
imaging with simultaneous low-intensity 405 nm activation light
switches only a small number of fluorophores to the on-state
within each frame so that they can be localized individually
(Fig. 8c).
A FP marker that combines both photoactivation modes
such as mIrisFP permits pulse-chase imaging experiments with
sub-diffraction resolution in live cells by using dual-color
SMLM.51 Green-to-red photoconversion allows for photo-
induced tagging and chasing of a subset of proteins in the cell,
as discussed in the previous subsection, and the photoswitching
capability of the green and red fluorophore species can be used
for SMLM (Fig. 8c). Notably, this imaging scheme requires that
the probability of photoconversion is less than the one of
photoswitching the green chromophore with 405 nm light.
We first demonstrated super-resolution pulse-chase imaging
in experiments aimed to visualize the dynamics of focal adhesion
complexes, which are known to continuously assemble and
disassemble during cell migration. For imaging, we used live
HeLa cells expressing a paxillin–mIrisFP fusion protein after
Fig. 7 Application of EosFP and variants in pulse-chase experiments. (a)
Cell tracking. The mRNA of tetrameric EosFP was microinjected into a
Xenopus laevis oocyte, so that all descendant cells express the marker as
shown for stage 2 (two cells). At stage 3 (four cells), EosFP molecules in
one cell were selectively photoconverted to the red state and the des-
cendant cells were tracked over time. (b) Organelle tracking. Mitochondria
in rabbit kidney cells were labeled with tdEosFP fused to a mitochondrial
targeting signal. After photoconversion in the region marked by the violet
square by focused 405 nm irradiation, the red-labeled markers were
followed over time. (c) Protein tracking. Parts of the cytoskeleton of a
HeLa cell are highlighted by RITA-mEosFPthermo. After photoconversion
of the FPs in the region marked by the violet circle at time zero, red-
emitting RITA proteins appeared within 20 s in the region marked by the
white square in the leftmost image (see close-ups at 0, 20 and 40 s on the
right). Adapted from ref. 58 with permission from Wiley-VCH, copyright
2011.
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transfection. Paxillin is a multidomain adaptor protein and a
crucial component of focal adhesions, as shown in the diffraction-
limited image obtained by total internal reflection (TIRF)
microscopy (Fig. 9a). First, a SMLM image of focal adhesion
points was taken, using photoswitching of green mIrisFP
(Fig. 9b). Then, mIrisFP molecules in the region marked by the
violet oval in Fig. 9b were photoconverted to the red form. After
75 s, the SMLM image taken using photoswitching of red
mIrisFP reveals that a significant fraction of the tagged
molecules appeared in locations outside the irradiated region
(Fig. 9c). A patch of focal adhesions (marked with a circle in
Fig. 9b–d) was already present while the green image was taken
(Fig. 9b) and grew in strength over the following 600 s by
recruiting red-converted paxillin–mIrisFP from the photo-
conversion region (Fig. 9c and d).
Dual-channel SMLM
Oftentimes, simultaneous imaging of two target proteins with
sub-diffraction resolution is desirable, e.g., to analyze their
mutual interaction. Dual-channel SMLM can be realized by
using fluorescent markers with different photoactivation
mechanisms, e.g., mEosFPthermo and mIrisGFP. The following
imaging strategy ensures complete decoupling of the two
channels: First, a SMLM image of mEosFPthermo is captured
in the red channel using 405 nm photoconversion and 561 nm
excitation light. Once all green mEosFPthermo molecules are
depleted by photoconversion and subsequent bleaching, a SMLM
image of mIrisGFP is acquired in the green channel using 473 nm
(off-switching) excitation and 405 nm (on-switching) light.
We have employed this approach to study desmin, a muscle-
specific intermediate filament protein, in live cells. Desmin
mutations have been implicated in various muscle diseases and
are known to cause formation of protein aggregates. To mimic
the clinically relevant heterozygous situation, we transfected
SW-13 (adrenal cortex carcinoma) cells with equal amounts of
plasmid for co-expression of mIrisGFP fused to wild-type des-
min and mEosFPthermo fused to desmin mutant Asn116Ser
(and other variants).138 Notably, SW-13 cells do not express
desmin on their own. Dual-channel SMLM revealed that
filaments as well as aggregates existed within the same cells,
both of them containing wild-type and Asn116Ser mutant
desmin (Fig. 10). By contrast, homozygous transient expression
revealed that wild-type desmin assembled into filamentous
networks, whereas the Asn116Ser mutant formed cytoplasmic
Fig. 8 Schematic depictions of SMLM. The fluorescence emission properties of the inactive (‘‘off’’) and active (‘‘on’’) chromophore species are indicated
by the color code of the lettering. Grey: dark, non-emitting; green: green-emitting; magenta: red-emitting. (a) SMLM based on irreversible green-to-red
photoconversion by using 405 nm light activation. (b) SMLM based on photoconversion by using dual-color (488 nm/B700 nm), i.e., primed light
activation. (c) SMLM based on reversible photoswitching (shown for the green chromophore).
Fig. 9 Dual-color SMLM combined with pulse-chase imaging on a live HeLa cell. (a) TIRF microscopy image of green paxillin–mIrisFP located at focal
adhesions. (b) SMLM reconstruction using photoswitching of green mIrisFP. Afterwards, mIrisFP molecules in the region marked by the violet oval were
irradiated for 30 s with 405 nm light for green-to-red photoconversion. (c and d) SMLM images of red paxillin–mIrisFP (c) 75 s and (d) 600 s after
photoconversion.
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aggregates. Interestingly, the localization patterns were found
to vary from mutant to mutant.138
Primed conversion offers an alternative approach to dual-
channel super-resolution SMLM, requiring only a single wave-
length for fluorescence excitation. To this end, we use two
photoconverting FP markers, one capable of regular 405 nm
photoconversion and the other one of primed photoconversion.
We can then distinguish the two FPs, which have essentially
identical spectral properties, solely on the basis of their
susceptibility to the different photoconversion methods.
To demonstrate this approach, we fused (405 nm converting)
mEos2 to E-MAP-115 139 and (primeable) pr-mEos2 to Lifeact140
to visualize microtubules and actin fibers, respectively. In the
regular wide-field image, the green-emitting mEos2 and
pr-mEos2 are indeed indistinguishable (Fig. 11a). Then, we
collected a SMLM image of the red-emitting LifeAct-pr-mEos2
using primed photoconversion (Fig. 11b). Subsequently, we
imaged the remaining E-MAP-115-mEos2 markers, which do
not convert under primed conversion illumination, by SMLM
using 405 nm photoconversion (Fig. 11c). The overlay image of
the two channels is shown in Fig. 11d.
Quantitative SMLM approaches
Quantitative SMLM goes beyond mere imaging and can provide
insight into biomolecular dynamics, clustering and oligomer-
ization of proteins in biological systems.133 SMLM lends itself
to protein quantification, as photons are collected from each
individual photoactivated FP until, in the ideal case, its
fluorophore photobleaches. However, FPs typically have
long-lived, non-emissive states from which they can recover
thermally or by light-activation.141 Thus, they undergo multiple,
temporally separated activation-deactivation cycles, leading to
overcounting the FPs or FP fusion constructs. By contrast,
undercounting can result from incomplete maturation and
photoconversion. For accurate counting, it is therefore important
to characterize the photophysical properties of the FP label and
include this information in the analysis.142–144 By taking the number
of photophysical (bright and dark) states, the kinetics of inter-
conversion, and the fraction of active fluorophores into account,
the number of molecules can be determined from the blinking
statistics. Hummer et al.145 used this approach to extract oligomer-
ization states of membrane-bound CD86-mEos2, VSVG-mEos2, and
CD80-mEos2 from SMLM data.146 Furthermore, Krueger et al.147
used quantitative SMLM to determine the oligomerization state of
the toll-like receptor TLR4 fused to mEos2 in HEK 293 cells in the
presence and absence of the co-receptors MD2 and CD14 and in
response to different lipopolysaccharide ligands.
Manley et al.78 combined SMLM with single-particle tracking
(SPT). By taking successive SMLM image frames of the membrane
proteins Gag and VSVG fused to tdEosFP and linking the signals
of the same molecule in consecutive frames according to their
proximity, they reconstructed short single-molecule trajectories.
Here, sequential photoactivation of a small set of FP molecules in
each image facilitates linking the signals associated with a
particular FP over successive images and allows tracking at a
much higher fluorophore density than in traditional SPT, where
all fluorescent labels are simultaneously active.
Fig. 10 Dual-channel SMLM of SW-13 cells co-expressing wild-type desmin fused to mIrisGFP and desmin mutant Asn116Ser fused to mEosFPthermo.
(a and b) SMLM images of (a) the wild-type desmin fusion protein using photoswitching of mIrisFP and (b) the mutant fusion protein using 405 nm
photoconversion of mEosFPthermo. (c) Dual-color (overlay) SMLM image. Scale bar, 1 mm. Adapted from ref. 138 with permission from American Society
for Biochemistry and Molecular Biology, copyright 2012.
Fig. 11 Sequential dual-channel SMLM using EosFP variants with orthogonal green-to-red photoconversion modes. (a) Widefield image of a HeLa cell,
with actin filaments and microtubules labeled with LifeAct-pr-mEos2 and E-MAP-115-mEos2, respectively. The green emission from the two markers is
indistinguishable. (b) SMLM of red-converted LifeAct-pr-mEos2 using primed photoconversion (488/642 nm). (c) SMLM of red-converted E-MAP-115-
mEos2 using 405 nm photoconversion, with the fluorescence of red-emitting mEos2 depicted in blue color to distinguish the two markers in the overlay
shown in (d). Scale bar, 10 mm. Adapted from ref. 81 with permission from John Wiley and Sons, copyright 2017.
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In our lab, we have studied the transport of vesicles to and
from the hyphal tip of live Aspergillus nidulans cells by
combining SMLM with high-speed pulse-chase imaging.148 We
found that the chitin synthase ChsB (fused to mEosFPthermo)
was transported from the cell body to the hyphal tip and vice
versa at two different speeds. By using motor protein deletion
mutants, the fast movements (7–10 mm s1) were assigned to
transport of secretory vesicles loaded with ChsB by kinesin-1,
and the slower ones (2–7 mm s1) to transport of early endo-
somes loaded with ChsB by kinesin-3.
Correlative light and electron microscopy (CLEM)
Multi-channel imaging can also be performed by using two
entirely different modalities, such as electron microscopy (EM),
optical microscopy, Raman microscopy or magnetic resonance
imaging. Such correlative approaches can provide complementary
information, as they are generally based on different mechanisms
for contrast generation. Correlative light and electron microscopy
(CLEM) combines EM for ultrastructural analysis with optical
microscopy, most often, fluorescence microscopy for visualizing
proteins or organelles that are specifically tagged by fluorescent
markers. This approach has become much more powerful with
the advent of super-resolution optical microscopy, which closes
the resolution gap between EM and optical microscopy.
Before EM data collection, samples are typically fixed,
stained with osmium tetroxide (OsO4), a widely used contrast
agent that binds to lipid membranes, and embedded in a resin.
Unfortunately, most FPs respond to OsO4 staining with a loss of
fluorescence, precluding their use in CLEM. To combine
transmission EM (TEM) and SMLM based on labeling with
photoconverting EosFP-type markers, Paez-Segala et al.83
engineered and characterized a variety of mEos2 mutants.
Two of them, mEos4a and mEos4b, were much more resistant
to heavy staining (1%) with OsO4 than mEos2, mEos3.1 and
mEos3.2, both in the green and, after photoconversion, in the
red forms, thus enabling correlative SMLM and high-quality
TEM. Very recently, Fu et al.84 introduced three more mutations
into mEos4b to obtain variant mEosEM, for which they reported
an improved performance after sample embedding in epon, an
epoxy resin that is harder than the low-polymerization-
temperature hydrophilic resin, glycidyl methacrylate, used by
Paez-Segala et al.83 and better preserves the ultrastructure of the
specimens. We note that, after epon embedding, mEosEM did
no longer photoconvert but showed reversible photoswitching in
the green form, which can be exploited for SMLM.
Nonlinear structured illumination microscopy
Structured illumination microscopy (SIM) is a linear fluorescence
imaging technique, offering up to two-fold resolution enhance-
ment by applying stripe-like periodically patterned illumination.149
Its nonlinear extension, saturated structured illumination micro-
scopy (SSIM),150 enables super-resolution imaging by using high
excitation power to drive fluorophores into saturation. A non-linear
excitation/emission response, which is the origin of the additional
resolution enhancement of SSIM,151 can also be generated with
photoswitchable FP markers, using orders of magnitude less laser
power, however. This imaging modality was termed patterned
activation nonlinear structured illumination microscopy (PA NL-
SIM).152 Patterned activation of the FP markers is followed by
patterned excitation and readout of the emission. More specifi-
cally, a set of raw wide field images is recorded by shifting and
rotating the activation/illumination pattern. The super-resolution
image is reconstructed from the raw images based on the known
illumination pattern. Different from SMLM, which favors photo-
activatable FPs emitting all their photons in a single burst and
featuring a high on/off contrast ratio for localization, PA NL-SIM
can tolerate photoswitchable FP markers with lower contrast ratio.
It demands, however, that its photon budget, i.e., all photons
emitted prior to photobleaching, can be expended over up to
hundreds of on–off cycles without a significant decay in photon
emission per cycle and, for live imaging, without adding any toxic
anti-bleaching chemicals.153,154 Zhang et al.155 engineered an FP
starting from mEos3.1 with optimal properties for PA NL-SIM,
which they denoted Skylan-NS. Using PA NL-SIM with total
internal reflection microscopy (TIRF) excitation, Betzig and
coworkers152 demonstrated the excellent performance of
Skylan-NS. They imaged caveolae, flask-shaped invaginations of
the plasma membrane with a diameter of 50–100 nm (Fig. 12),
formed by oligomerization of the caveolin protein, using Skylan-NS
fused to caveolin.
Super-resolution optical fluctuation imaging (SOFI)
Unlike SMLM, which uses the emission intensity to localize
many individual fluorophores for reconstruction of super-
resolved images, SOFI relies on temporal fluctuations of the
intensity of individual emitters contributing to each pixel of the
image.156 Therefore, SOFI requires fluorophores with flickering
emission intensity. To produce a super-resolved SOFI image, a
time series of tens to hundreds of images is acquired, and the
intensity fluctuations of each individual pixel (of sub-resolution
size) are analyzed by calculating nth-order cumulants, which
are functions related to nth-order correlation functions.156 An
image generated from the nth-order cumulant yields an n-fold
enhanced resolution over the regular (intensity) image.157 The
super-resolved image is background-free and the pixel
amplitudes represent the number of fluorescent labels if they
exhibit the same emission properties, including the intensity
levels of the dark (off) and bright (on) states and the photo-
switching kinetics.
Photoswitchable FPs have been successfully employed for
SOFI, exploiting their ability to repeatedly switch between a
bright on-state and a dark off-state.158 Zhang et al.159 developed
Skylan-S from mEos2 and reported beneficial properties especially
for SOFI, including a high intensity in the on-state and an
enhanced contrast ratio and photobleaching stability. To
demonstrate that Skylan-S is an excellent probe for SOFI, they
imaged clathrin-coated pits (CCPs) in living U2OS cells
(Fig. 13), using a fusion protein of clathrin and Skylan-S. CCPs
are cell membrane invaginations with diameters of 100–200 nm
mediating endocytosis. They grow over the course of several ten
seconds, and finally bud off to form intracellular vesicles.160
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Conclusions and outlook
Optical fluorescence microscopy, especially super-resolution
imaging, has been established as one of the most powerful
and versatile tools for studying the molecular basis of life. The
method crucially relies on our ability to label biomolecules
selectively with fluorescent markers, which is an unavoidable
perturbation of the system. For live-cell imaging with super-
resolution, FPs will be indispensable due to their genetic
encodability, which ensures simple labeling procedures. Recent
advances in gene editing, notably, CRISPR/Cas9, have made
powerful tools available for targeted gene modification, e.g., to
introduce a FP domain, at a specific locus, making the FP
labeling approach even more powerful. Gene editing ensures
that expression levels are more native-like and artifacts due to
transient overexpression can be avoided. However, the smaller
numbers of expressed labels (with respect to overexpression via
transient transfection) make imaging experiments more
demanding and call for highly sensitive microscopes and
the brightest (photoactivatable) labels. Accordingly, the quest
for FPs with enhanced brightness, suitable photoactivation
properties, and a large photon budget will continue.
In this review, we have focused on photoactivatable FPs of
the EosFP clade and shown that only a few modifications of the
natural amino acid sequence resulted in many FP variants
with improved and sometimes surprising new properties
advantageous for certain imaging techniques. We anticipate
that the usual trial-and-error or random approaches for
identifying suitable sequence modifications will be increasingly
substituted by rational engineering, based on better under-
standing of the structure–function relationships in FPs, giving
guidance for the development of further improved EosFP
variants and other GFP-type proteins, e.g., with respect to the
intriguing array of light-tunable optical properties. In fact,
whereas all EosFP variants included in this review have shown
their usefulness in certain applications, they are by no means
optimized, easy-to-use devices. For example, apart from regular
photoactivation, FPs exhibit intermittency of their fluorescence
emission due to transient (and often long-lived) population of
non-emissive states. This can be a blessing in some applications
(e.g., shelving in dark states can reduce photobleaching effects137
) but a curse in others (e.g., an already registered FP may be
mistaken for a different one upon recovery from a long-lived
dark state in quantitative SMLM). Often, carefully adjusted
sample illumination with multiple laser wavelengths can help
release FPs from these states for best imaging
performance.51,108,130 In view of the continuous appearance of
Fig. 12 Images of caveolae on the plasma membrane of a live COS-7 cell expressing Skylan-NS-caveolin at 23 1C. TIRF images (a) with deconvolution
and combined with (b) SIM, (c) PA NL-SIM, and (d) saturated PA NL-SIM (45-nm resolution) are shown. Insets in (a–d) show individual caveolae. (e)
Diversity of caveolae ring diameters as visualized by PA NL-SIM. (f) Larger rings may represent surface-docked vesicles. (g) Clusters of caveolae
reminiscent of clathrin plaques. Scale bars, 100 nm. Adapted from ref. 152 with permission from American Association for the Advancement of Science,
copyright 2015.
Fig. 13 Widefield and SOFI images of CCPs in live U2OS cells, using
clathrin fused with Skylan-S for labeling. (a–c) TIRFM images. (d–f) SOFI
images from second-order cumulants. (g–i) SOFI images from third-order
cumulants. (b, e and h) Close-up views of the boxed regions in panels a, d,
and g, respectively. (c, f and i) Close-up views of the boxed regions in
panels b, e, and h, respectively. Scale bars, 10 mm (a, d and g), 3 mm (b, e and
h), and 500 nm (c, f and i). Adapted from ref. 159 with permission from
American Chemical Society, Copyright 2015.
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new variants even after almost 20 years of EosFP engineering, we
are looking forward to further advanced variants, optimized for
specific applications.
Notably, there is a large pool of FP sequences in a variety of
animals that has not been systematically explored. Screening
campaigns may reveal FPs with new and advanced properties
that can be exploited for biological imaging. Therefore, we
envision that there are still considerable opportunities for
advances in FP marker technology. Likewise, we expect
progress with other genetically encoded labeling techniques
not covered in this review, e.g., chemical tags such as Halo or
SNAP for protein labeling161 or light-up aptamers for RNA
labeling.162–164 These approaches employ synthetic dyes with
excellent fluorescence properties, superior to those of FP-based
labels, but require an external supply of fluorophores, limiting
their versatility and ease of use. In view of the central role of
optical fluorescence microscopy in the life sciences, there can be no
doubt that the quest for bright, selective and sophisticated optical
fluorescence markers for the imaging of biological structures will
continue to be a hot research topic for years to come.
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